Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)
CNY 51.13
(0.08%)
CNY 51.13
(0.08%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 4.3 Billion CNY | 10.14% |
| 2022 | 3.9 Billion CNY | -13.77% |
| 2021 | 4.53 Billion CNY | -28.41% |
| 2020 | 6.32 Billion CNY | 18.78% |
| 2019 | 5.32 Billion CNY | 31.05% |
| 2018 | 4.06 Billion CNY | 26.39% |
| 2017 | 3.21 Billion CNY | 24.25% |
| 2016 | 2.58 Billion CNY | 19.22% |
| 2015 | 2.17 Billion CNY | 43.28% |
| 2014 | 1.51 Billion CNY | 22.41% |
| 2013 | 1.23 Billion CNY | 14.92% |
| 2012 | 1.07 Billion CNY | 22.9% |
| 2011 | 876.61 Million CNY | 21.05% |
| 2010 | 724.17 Million CNY | 8.78% |
| 2009 | 665.73 Million CNY | 57.4% |
| 2008 | 422.94 Million CNY | 2.43% |
| 2007 | 412.92 Million CNY | 99.82% |
| 2006 | 206.64 Million CNY | 27.39% |
| 2005 | 162.22 Million CNY | 32.3% |
| 2004 | 122.62 Million CNY | 29.73% |
| 2003 | 94.51 Million CNY | 19.72% |
| 2002 | 78.95 Million CNY | -2.71% |
| 2001 | 81.15 Million CNY | 24.33% |
| 2000 | 65.27 Million CNY | 27.15% |
| 1999 | 51.33 Million CNY | 18.74% |
| 1998 | 43.22 Million CNY | 5.26% |
| 1997 | 41.07 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 1.36 Billion CNY | 65.2% |
| 2024 Q3 | 1.18 Billion CNY | -42.42% |
| 2024 Q2 | 2.06 Billion CNY | 50.69% |
| 2023 Q1 | 1.23 Billion CNY | 69.07% |
| 2023 Q4 | 828.65 Million CNY | -28.9% |
| 2023 Q2 | 1.06 Billion CNY | -13.72% |
| 2023 Q3 | 1.16 Billion CNY | 9.01% |
| 2023 FY | 4.3 Billion CNY | 10.14% |
| 2022 Q2 | 882.38 Million CNY | -28.66% |
| 2022 Q1 | 1.23 Billion CNY | 282.94% |
| 2022 Q4 | 732.91 Million CNY | -30.47% |
| 2022 FY | 3.9 Billion CNY | -13.77% |
| 2022 Q3 | 1.05 Billion CNY | 19.46% |
| 2021 Q3 | 1.53 Billion CNY | 31.47% |
| 2021 Q2 | 1.17 Billion CNY | -21.75% |
| 2021 FY | 4.53 Billion CNY | -28.41% |
| 2021 Q1 | 1.49 Billion CNY | -27.7% |
| 2021 Q4 | 323.01 Million CNY | -79.02% |
| 2020 FY | 6.32 Billion CNY | 18.78% |
| 2020 Q1 | 1.31 Billion CNY | -17.43% |
| 2020 Q2 | 1.34 Billion CNY | 2.36% |
| 2020 Q3 | 1.59 Billion CNY | 18.58% |
| 2020 Q4 | 2.06 Billion CNY | 29.63% |
| 2019 Q1 | 1.19 Billion CNY | 3.37% |
| 2019 FY | 5.32 Billion CNY | 31.05% |
| 2019 Q2 | 1.21 Billion CNY | 2.29% |
| 2019 Q3 | 1.32 Billion CNY | 8.41% |
| 2019 Q4 | 1.59 Billion CNY | 20.47% |
| 2018 Q2 | 960.31 Million CNY | 1.14% |
| 2018 Q3 | 1 Billion CNY | 4.36% |
| 2018 FY | 4.06 Billion CNY | 26.39% |
| 2018 Q1 | 949.45 Million CNY | 6.81% |
| 2018 Q4 | 1.15 Billion CNY | 15.12% |
| 2017 Q3 | 754.33 Million CNY | -0.95% |
| 2017 Q1 | 811.84 Million CNY | 22.94% |
| 2017 Q4 | 888.88 Million CNY | 17.84% |
| 2017 Q2 | 761.58 Million CNY | -6.19% |
| 2017 FY | 3.21 Billion CNY | 24.25% |
| 2016 Q4 | 660.36 Million CNY | 7.5% |
| 2016 Q1 | 684.33 Million CNY | 14.07% |
| 2016 Q3 | 614.26 Million CNY | -2.49% |
| 2016 FY | 2.58 Billion CNY | 19.22% |
| 2016 Q2 | 629.98 Million CNY | -7.94% |
| 2015 Q1 | 547.37 Million CNY | 37.28% |
| 2015 Q4 | 599.93 Million CNY | 17.54% |
| 2015 Q3 | 510.39 Million CNY | -0.68% |
| 2015 Q2 | 513.86 Million CNY | -6.12% |
| 2015 FY | 2.17 Billion CNY | 43.28% |
| 2014 Q1 | 390.34 Million CNY | 24.93% |
| 2014 FY | 1.51 Billion CNY | 22.41% |
| 2014 Q4 | 398.71 Million CNY | 11.73% |
| 2014 Q3 | 356.85 Million CNY | -3.46% |
| 2014 Q2 | 369.64 Million CNY | -5.31% |
| 2013 Q3 | 283.64 Million CNY | -7.11% |
| 2013 Q2 | 305.35 Million CNY | -9.3% |
| 2013 FY | 1.23 Billion CNY | 14.92% |
| 2013 Q1 | 336.65 Million CNY | 23.27% |
| 2013 Q4 | 312.45 Million CNY | 10.16% |
| 2012 Q4 | 273.1 Million CNY | 10.53% |
| 2012 Q1 | 301.94 Million CNY | 47.35% |
| 2012 Q2 | 255.26 Million CNY | -15.46% |
| 2012 Q3 | 247.07 Million CNY | -3.21% |
| 2012 FY | 1.07 Billion CNY | 22.9% |
| 2011 Q3 | 204.07 Million CNY | -4.31% |
| 2011 Q4 | 204.91 Million CNY | 0.41% |
| 2011 Q2 | 213.25 Million CNY | -16.16% |
| 2011 FY | 876.61 Million CNY | 21.05% |
| 2011 Q1 | 254.36 Million CNY | 58.07% |
| 2010 Q4 | 160.91 Million CNY | -6.51% |
| 2010 Q1 | 203.32 Million CNY | 5.38% |
| 2010 Q2 | 187.81 Million CNY | -7.63% |
| 2010 Q3 | 172.11 Million CNY | -8.36% |
| 2010 FY | 724.17 Million CNY | 8.78% |
| 2009 Q4 | 192.94 Million CNY | 93.7% |
| 2009 FY | 665.73 Million CNY | 57.4% |
| 2009 Q2 | 160.47 Million CNY | -24.56% |
| 2009 Q1 | 212.71 Million CNY | 43.32% |
| 2009 Q3 | 99.6 Million CNY | -37.93% |
| 2008 Q4 | 148.41 Million CNY | 79.44% |
| 2008 Q3 | 82.71 Million CNY | -29.62% |
| 2008 Q2 | 117.52 Million CNY | 58.21% |
| 2008 Q1 | 74.28 Million CNY | -54.55% |
| 2008 FY | 422.94 Million CNY | 2.43% |
| 2007 Q2 | 80.33 Million CNY | 9.42% |
| 2007 Q4 | 163.46 Million CNY | 70.8% |
| 2007 Q3 | 95.7 Million CNY | 19.13% |
| 2007 Q1 | 73.41 Million CNY | 45.0% |
| 2007 FY | 412.92 Million CNY | 99.82% |
| 2006 Q2 | 56.23 Million CNY | 9.82% |
| 2006 Q1 | 51.2 Million CNY | 58.33% |
| 2006 Q4 | 50.63 Million CNY | 4.34% |
| 2006 FY | 206.64 Million CNY | 27.39% |
| 2006 Q3 | 48.52 Million CNY | -13.71% |
| 2005 Q1 | 39.81 Million CNY | 24.68% |
| 2005 Q2 | 36.54 Million CNY | -8.22% |
| 2005 Q3 | 53.52 Million CNY | 46.48% |
| 2005 Q4 | 32.34 Million CNY | -39.58% |
| 2005 FY | 162.22 Million CNY | 32.3% |
| 2004 Q2 | 20.45 Million CNY | -30.16% |
| 2004 FY | 122.62 Million CNY | 29.73% |
| 2004 Q4 | 31.93 Million CNY | -18.72% |
| 2004 Q1 | 29.28 Million CNY | -11.35% |
| 2004 Q3 | 39.28 Million CNY | 92.06% |
| 2003 Q1 | 22.55 Million CNY | 32.55% |
| 2003 Q3 | 25.98 Million CNY | 100.69% |
| 2003 FY | 94.51 Million CNY | 19.72% |
| 2003 Q4 | 33.03 Million CNY | 27.16% |
| 2003 Q2 | 12.94 Million CNY | -42.61% |
| 2002 Q4 | 17.01 Million CNY | 14.4% |
| 2002 Q2 | 28.83 Million CNY | 58.25% |
| 2002 Q1 | 18.22 Million CNY | 0.0% |
| 2002 FY | 78.95 Million CNY | -2.71% |
| 2002 Q3 | 14.87 Million CNY | -48.42% |
| 2001 FY | 81.15 Million CNY | 24.33% |
| 2000 FY | 65.27 Million CNY | 27.15% |
| 1999 FY | 51.33 Million CNY | 18.74% |
| 1998 FY | 43.22 Million CNY | 5.26% |
| 1997 FY | 41.07 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 2.79 Billion CNY | -53.804% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 591.57 Million CNY | -627.287% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 57 Million CNY | -7448.044% |
| Aurora Optoelectronics Co.,Ltd. | -675.27 Million CNY | 737.136% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -38.27 Million CNY | 11340.808% |
| NanJing Pharmaceutical Company Limited | 577.82 Million CNY | -644.591% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 90.07 Million CNY | -4676.315% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.16 Billion CNY | -268.411% |